Showing results (401-410 of 411) with videos related to

Sort By:
Pageof 42
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic ScreenMarina Bukhtiyarova, Erica M Cook, Paula J Hancock, et al.
Chembiochem : a European Journal of Chemical Biology|April 18, 2023
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease InhibitorsPatrick Moon, Charlotte M Zammit, Qian Shao, et al.
Journal of the American Chemical Society|December 9, 2022
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity RelationshipsMichael A Plotkin, Marc Labroli, Jeffrey Schubert, et al.
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.
Cell Reports|December 13, 2018
Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor ImmunityKelsey E Sivick, Anthony L Desbien, Laura Hix Glickman, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosisJohn E Landers, Judith Melki, Vincent Meininger, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 42